Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    4,999.74
    -71.89 (-1.42%)
     

  • Dow

    37,818.07
    -642.85 (-1.67%)
     

  • Nasdaq

    15,409.85
    -302.90 (-1.93%)
     

  • Bitcoin USD

    63,237.99
    -2,681.69 (-4.07%)
     

  • CMC Crypto 200

    1,370.06
    -12.52 (-0.91%)
     

  • FTSE 100

    8,053.41
    +13.03 (+0.16%)
     

  • Gold

    2,332.50
    -5.90 (-0.25%)
     

  • Crude Oil

    82.39
    -0.42 (-0.51%)
     

  • 10-Yr Bond

    4.7250
    +0.0730 (+1.57%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Why Shares of Organogenesis Holdings Jumped Thursday

Jim Halley, The Motley Fool
·2-min read
Why Shares of Organogenesis Holdings Jumped Thursday

Shares of Organogenesis Holdings (NASDAQ: ORGO) were up more than 30% Thursday afternoon after the healthcare company released first-quarter earnings after market close on Wednesday. Organogenesis makes products for the advanced wound care, surgical, and sports medicine markets, using regenerative tissue-based technologies that heal chronic and acute wounds. In the company's earnings call, Organogenesis president and CEO Gary Gillheeney said the biggest drivers of sales in the quarter came from its PuraPly antimicrobial wound mix and non-PuraPly products, such as NuShield, a dehydrated placental allograft wound covering.

Continue reading